RAPT Therapeutics (RAPT) shares were up about 1.3% in recent Wednesday trading after JPMorgan upgraded the stock to neutral from underweight.
Trading volume stood at more than 18,500 shares, compared with a daily average of about 118,000.
Price: 11.69, Change: +0.16, Percent Change: +1.34